Works matching IS 02572753 AND DT 2017 AND VI 35 AND IP 3
Results: 24
Preface.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 3, p. 157, doi. 10.1159/000452153
- By:
- Publication type:
- Article
Falk Symposium Series.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 3, p. 293, doi. 10.1159/000453347
- Publication type:
- Article
Nor-Ursodeoxycholic Acid as a Novel Therapeutic Approach for Cholestatic and Metabolic Liver Diseases.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 3, p. 288, doi. 10.1159/000454904
- By:
- Publication type:
- Article
Therapeutic Mechanisms of Bile Acids and Nor-Ursodeoxycholic Acid in Non-Alcoholic Fatty Liver Disease.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 3, p. 282, doi. 10.1159/000454853
- By:
- Publication type:
- Article
Bile Acids in Polycystic Liver Diseases: Triggers of Disease Progression and Potential Solution for Treatment.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 3, p. 275, doi. 10.1159/000450989
- By:
- Publication type:
- Article
Apical Sodium-Dependent Transporter Inhibitors in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 3, p. 267, doi. 10.1159/000450988
- By:
- Publication type:
- Article
Roles of Ileal ASBT and OSTα–OSTβ in Regulating Bile Acid Signaling.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 3, p. 261, doi. 10.1159/000450987
- By:
- Publication type:
- Article
Extended Abstract: Deficiency of Sodium Taurocholate Cotransporting Polypeptide (SLC10A1): A New Inborn Error of Metabolism with an Attenuated Phenotype.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 3, p. 259, doi. 10.1159/000450984
- By:
- Publication type:
- Article
Bile Acid Uptake Transporters as Targets for Therapy.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 3, p. 251, doi. 10.1159/000450983
- By:
- Publication type:
- Article
Crosstalk between Bile Acids and Gut Microbiota and Its Impact on Farnesoid X Receptor Signalling.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 3, p. 246, doi. 10.1159/000450982
- By:
- Publication type:
- Article
Intestinal Farnesoid X Receptor and Takeda G Protein Couple Receptor 5 Signaling in Metabolic Regulation.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 3, p. 241, doi. 10.1159/000450981
- By:
- Publication type:
- Article
Role of the G Protein-Coupled Bile Acid Receptor TGR5 in Liver Damage.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 3, p. 235, doi. 10.1159/000450917
- By:
- Publication type:
- Article
The Role of Inflammation in the Mechanisms of Bile Acid–Induced Liver Damage.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 3, p. 232, doi. 10.1159/000450916
- By:
- Publication type:
- Article
Mechanisms of Tauroursodeoxycholate-Mediated Hepatoprotection.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 3, p. 224, doi. 10.1159/000450915
- By:
- Publication type:
- Article
The Emerging Role of Soluble Adenylyl Cyclase in Primary Biliary Cholangitis.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 3, p. 217, doi. 10.1159/000450914
- By:
- Publication type:
- Article
Bile Acids and Deregulated Cholangiocyte Autophagy in Primary Biliary Cholangitis.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 3, p. 210, doi. 10.1159/000450913
- By:
- Publication type:
- Article
Regulation of Liver Energy Balance by the Nuclear Receptors Farnesoid X Receptor and Peroxisome Proliferator Activated Receptor α.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 3, p. 203, doi. 10.1159/000450912
- By:
- Publication type:
- Article
Progress in the Molecular Characterization of Hepatobiliary Transporters.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 3, p. 197, doi. 10.1159/000450911
- By:
- Publication type:
- Article
Impact of Fibroblast Growth Factors 19 and 21 in Bariatric Metabolism.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 3, p. 191, doi. 10.1159/000450910
- By:
- Publication type:
- Article
Farnesoid X Receptor an Emerging Target to Combat Obesity.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 3, p. 185, doi. 10.1159/000450909
- By:
- Publication type:
- Article
Intestinal Farnesoid X Receptor Signaling Modulates Metabolic Disease.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 3, p. 178, doi. 10.1159/000450908
- By:
- Publication type:
- Article
Disease-Associated Changes in Bile Acid Profiles and Links to Altered Gut Microbiota.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 3, p. 169, doi. 10.1159/000450907
- By:
- Publication type:
- Article
Role of the Intestinal Microbiome in Cholestatic Liver Disease.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 3, p. 166, doi. 10.1159/000450906
- By:
- Publication type:
- Article
Fibroblast Growth Factor 15/19 in Hepatocarcinogenesis.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 3, p. 158, doi. 10.1159/000450905
- By:
- Publication type:
- Article